Estimates risk of early major bleeding in patients with acute pulmonary embolism (PE). This validated risk assessment tool helps clinicians identify PE patients at higher risk for bleeding complications within 30 days of diagnosis, assisting in treatment decisions and management planning.
Awaiting Clinical Input
Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.
The Pulmonary Embolism Syncope-Anemia-Renal Dysfunction (PE-SARD) Score is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.
Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.
Low bleeding risk
Intermediate bleeding risk
High bleeding risk
Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.
Open in Web AppClinical Decision Support (CDS) Notice & Legal Disclaimer
This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.